About the journal

New journal – launching September 2016

BMJ Open Ophthalmology will launch in September 2016. The journal will have a distinct footprint in the ophthalmology and vision science community by addressing the needs of clinicians and scientists, fostering close interaction between basic, translational and clinical sciences.

The journal is offering an introductory full waiver of the Article Publishing Charge (APC) for articles submitted between 1st June and 31st August 2016. Find out more here.

Submit

Register to receive email alerts and stay connected to BMJ Open Ophthalmology.

Follow us on Twitter @BMJ_Ophth to receive the latest news and research updates for ophthalmologists, basic scientists and vision scientists.

Aims & Scope

BMJ Open Ophthalmology is a new Open Access journal published by BMJ. The journal publishes high-quality articles on basic, translational and clinical science covering all aspects of ophthalmology and vision science.

BMJ Open Ophthalmology will:

  • Publish a broad range of articles of particular clinical, scientific, educational or surgical value on a rapid publication schedule
  • Facilitate a close interaction between basic, translational and clinical sciences through publication and fostering interdisciplinary research
  • Provide an interactive digital platform that is freely available, unrestricted and immediately accessible
  • Provoke scientific debate and clinical commentary in which the readership, authors and public can engage and contribute through social media and multimedia


Editorial Board

 

Joint Editors-in-Chief

We are pleased to announce that Professor Colin E. Willoughby, BSc, MBChB, FRCOphth, MD and Professor Stephen B. Kaye, BSc, MBBCh, FRCOphth, MD, are the joint Editors-in-Chief of BMJ Open Ophthalmology.

Read their introductory Editorial Facilitating a close interaction between basic, translational and clinical science: BMJ Open Ophthalmology>>

Professor Colin E. Willoughby, BSc, MBChB, FRCOphth, MD and Professor Stephen B. Kaye, BSc, MBBCh, FRCOphth, MD

Professor Colin E. Willoughby
University of Liverpool
Liverpool, UK
C.Willoughby@liverpool.ac.uk

Professor Willoughby has a long-standing ambition and passion to apply the latest molecular biology techniques to improve the diagnosis, treatment and management of ocular disease. Appointed Professor of Ophthalmology at the University of Liverpool and part of the corneal and glaucoma services at the Royal Liverpool University Hospital; he currently leads a group of scientists and clinicians applying functional genomics to deliver personalised medicine, to determine disease risk and progression, response to treatment, understand disease mechanisms and ultimately translate new treatments into clinical practice. The main focus of this research is to improve the understanding, diagnosis and treatment of two major worldwide blinding disorders: corneal blindness and glaucoma.

Professor Stephen B. Kaye
University of Liverpool
Liverpool, UK
S.B.Kaye@liverpool.ac.uk

Professor Kaye has achieved an international reputation, contributing on national and international platforms to advance our knowledge of corneal transplantation, corneal angiogenesis, infections of the ocular surface, optical systems and the development of methods to analyse optical systems. Currently, he leads the Cornea and Ocular Surface Disease Service at The Royal Liverpool University Hospital and is Director of The Liverpool Research Eye Bank. Professor Kaye also leads the National Microbiology Infection Group and was chair of The Ocular Tissue Advisory Group whose efforts have directly impacted on patient care and improved the standards & outcomes of corneal transplantation.

 

Associate Editors

Cataract and Refractive Surgery
Dr Bernhard Steger

Medical University Innsbruck
Innsbruck, Austria
bernhard@steger.tirol

Cornea and Ocular Surface (Clinical)
Professor Stephanie Watson

Sydney Eye Hospital
Sydney, Australia
stephanie.watson@sydney.edu.au

Cornea and Ocular Surface (Basic Science)
Professor Darlene A. Dartt

Harvard Medical School
Massachusetts, USA
darlene_dartt@meei.harvard.edu

Global Ophthalmology
Dr David Yorston

NHS Greater Glasgow and Clyde
Glasgow, UK
dbyorston@btinternet.com/a>

Glaucoma
Professor Colm O’Brien

Mater Hospital School of Medicine
Dublin, Republic of Ireland
cobrien@mater.ie

Molecular Ophthalmology and Social Media
Dr Kevin Hamill

University of Liverpool
Liverpool UK
Kevin.Hamill@liverpool.ac.uk

Ocular Oncology
Dr Martina Angi

National Cancer Institute: IRCCS Foundation
Milan, Italy
Kevin.Hamill@liverpool.ac.uk

Retina
Professor David A. Eichenbaum

Retina Vitreous Associates of Florida
Florida, USA
deichenb@yahoo.com

Retina
Professor Jennifer I. Lim

Illinois Eye and Ear Infirmary
Illinois, USA
jennylim@uic.edu

Visual Science
Professor James Wolffsohn

Aston University
Birmingham, UK
j.s.w.wolffsohn@aston.ac.uk

Information for authors

Editorial Policies

BMJ Open Ophthalmology is an online-only Open Access journal that aims to operate a fast submission and review process with continuous publication online, to ensure that timely, up-to-date research is available worldwide. The journal adheres to a rigorous and transparent peer review process and adheres to the highest ethical standards concerning research conduct.

Submissions to the journal should be made through the journal’s online submission system available here.

Submission to BMJ Open Ophthalmology implies that the work described has not been accepted for publication elsewhere, that it is not under consideration for publication elsewhere and does not duplicate material already published.

Authors are encouraged to read our information for authors:

BMJ Open Ophthalmology levies an Article Publishing Charge (APC) that reflects the true cost of the services provided. The standard APC for an article is GBP 1,700 / EUR 2,380 / USD 3,000 (exclusive of VAT for UK and EU authors). Protocols have a discounted APC of GBP 1,000 / EUR 1,450 / USD 1,650. Articles are published under a Creative Commons licence to facilitate reuse of the content and authors retain copyright.

Manuscript Types

Please review the following descriptions of manuscript types and the required article lengths, illustrations and table limits, and references counts. Manuscripts should be as succinct as possible.

Original Research

Abstract Style / Limit: Structured 250
Word Limit: 4,000
Figure / Table Limit: 5
Reference Limit: 100

Original Research should include the following:

  • Title – include the research question and study design
  • Keywords – up to four
  • Structured Abstract – include the following headings “Objective”, “Methods and Analysis”, “Results” and “Conclusion”
  • Introduction
  • Materials and Methods
  • Results
  • Discussion

The abstract should be followed by a key messages box which outlines the significance of the study. This should address the following questions:

  • What is already known about this subject?
  • What are the new findings?
  • How might these results change the focus of research or clinical practice?

Authors are encouraged to submit their original data.

Protocol

Protocol manuscripts should report planned or ongoing studies. The journal will consider any study design, including observational studies and systematic reviews.

Protocols should include the following:

  • Title – include the study design
  • Structured Abstract – include the following headings “Introduction”, “Methods and Analysis” and “Ethics and Dissemination” and “Trial Registration Number”
  • Introduction
  • Methods and Analysis
  • Ethics and Dissemination

Review Article

These are mainly commissioned.

Abstract Style / Limit: Unstructured 250
Word Limit: 4,000
Figure / Table Limit: 5
Reference Limit: 100

Editorial

These are mainly commissioned.

Abstract Style / Limit: None
Word Limit: 2,000
Figure / Table Limit: 2
Reference Limit: 25

Email alerts

Register to receive email updates for BMJ Open Ophthalmology.

Options available:

  • Journal announcements: Stay connected to hear about the journal’s full launch, and its future developments
  • Online alerts: Receive an alert when a new article is published
  • Register to receive other news from BMJ on areas that are relevant to your medical specialty

FAQs

Questions

  1. What are the benefits of publishing in BMJ Open Ophthalmology?
  2. Is BMJ Open Ophthalmology indexed?
  3. How do I submit?
  4. My paper has just been rejected from the British Journal of Ophthalmology, can I transfer my paper to BMJ Open Ophthalmology?
  5. What is Open Access and an Article Publishing Charge (APC)?
  6. What APC applies to BMJ Open Ophthalmology?
  7. How do I pay?
  8. Does BMJ Open Ophthalmology offer discounts and waivers on the APC?
  9. Does BMJ Open Ophthalmology impose any copyright restrictions and who retains copyright of the Open Access articles?
  10. Will publishing in BMJ Open Ophthalmology be compliant with my funder mandates
  11. Which funding agencies allow direct use of grants to cover the APC?
  12. How do I subscribe?
  13. How is the article cited?
  14. What is the time to publication?
  15. How do I sign up to email alerts about articles published in BMJ Open Ophthalmology?
  16. Who do I contact if I would like more information about BMJ Open Ophthalmology?

 

Answers

  1. What are the benefits of publishing in BMJ Open Ophthalmology?

    • Open Access – International reach and discoverability through our Open Access model, making articles freely available to a global audience, with the copyright retained by the author.
    • Compliance with funder Open Access mandates – publishing in BMJ Open Ophthalmology enables you to fulfill the Open Access requirements of funders such as the NIH, Howard Hughes Medical Institute, Wellcome Trust and Research Councils UK, including using the CC-BY license
    • Rapid publication – articles are subject to stringent peer review and fast turnaround times, ensuring prompt publication through our continuous publication model
    • Trusted international brandsBMJ Open Ophthalmology maintains the scientific and international reputation of BMJ and its sister title British Journal of Ophthalmology
    • High readership visibility – BMJ online platform ensures papers are discoverable; newsworthy articles are press-released
  2. Is BMJ Open Ophthalmology indexed?

    As a new journal BMJ Open Ophthalmology is not yet indexed. It is our aim to apply for indexing as soon as it is appropriate.

  3. How do I submit?

    Manuscripts should be submitted via the BMJ Open Ophthalmology online manuscript submission site.

  4. My paper has just been rejected from British Journal of Ophthalmology, can I transfer my paper to BMJ Open Ophthalmology?

    Your article will not automatically be transferred to BMJ Open Ophthalmology if rejected from British Journal of Ophthalmology; you can however choose this option when submitting your article through the online submissions system. Your manuscript can also be transferred to BMJ Open Ophthalmology from any other journal published by BMJ.

    When submitting your article to BMJ Open Ophthalmology if rejected from British Journal of Ophthalmology. We will obtain your previous peer review records and expedite your manuscript, resulting in a reduced time to decision. Manuscripts will be evaluated separately by the BMJ Open Ophthalmology editorial team, with different criteria for acceptance. Submission to the journal does not guarantee acceptance.

    Please email the editorial office at info.bmjophth@bmj.com for help or more information on submissions.

  5. What is Open Access and an Article Publishing Charge (APC)?

    Open Access equates to unrestricted access. Open Access publishing strives to facilitate the the dissemination of research efficiently, effectively and equitably. All articles published in BMJ Open Ophthalmology are Open Access and are therefore available online in a permanent, universally accessible repository.
    The Article Publishing Charge (APC) covers the costs of the publication process (which would traditionally be covered via subscription fees), including:

    • Rigorous peer review through a maintained online submission system
    • Production costs such as copyediting, typesetting, and preparation for online publication
    • Continuous hosting of the article online, available worldwide
    • Marketing efforts to increase the article’s exposure
  6. What APC applies to BMJ Open Ophthalmology?

    BMJ Open Ophthalmology levies an APC that reflects the true cost of the services provided. The standard APC for an article is GBP 1,700 / EUR 2,380 EUR / USD 3,000 (exclusive of VAT for UK and EU authors). Protocols have a discounted APC of GBP 1,000 / EUR 1,450 / USD 1,650.

    **The journal is offering a introductory full waiver of the APC for articles submitted between 1st June and 30th June 2016.**

    There are no submission or page charges, and no colour charges. Payment of the APC may be made online by credit card, or by bank transfer following receipt of an invoice. Unless a waiver has been granted, accepted articles will not be published until payment has been received.

    Your institution may already have arranged to cover your publishing costs or you may be eligible for a discount. General information about BMJ’s Open Access Programme, including copyright policies and institutional memberships, is available via our author website.

    It is the journal’s policy to publish articles after the APC is received. BMJ does not refund an APC once paid.

  7. How do I pay the APC?

    The submitting author must confirm at the time of submission that they will organize payment should the article be accepted for publication. Prompt payment is advised as the article will not be published until payment is received.

    Payment can be made through any of the following methods:

    • Immediate payment online via credit card using a secure payment form as soon as the manuscript has been accepted.
    • An invoice can be generated. Following receipt of an invoice, payment must be made within 30 days.
  8. Does BMJ Open Ophthalmology offer discounts and waivers on the APC?

    The journal is offering an introductory full waiver of the APC for articles submitted between 1st June and 30th June 2016.

    BMJ Open Ophthalmology offers a 100% waiver to corresponding authors from institutions based in Hinari Group A countries, and a 50% discount to authors from institutions based in Hinari Group B countries.

    Check with your institution before paying the APC. Your publishing costs might be covered through the BMJ Open Access Programme, or you may be eligible for a discount. More information about the BMJ Open Access Programme, including general information on Open Access and copyright policies, is available via our author website.

  9. Does BMJ Open Ophthalmology impose any copyright restrictions, and who retains copyright of the Open Access articles?

    Authors retain copyright. Articles are published under a Creative Commons licence to facilitate reuse of the content. The standard licence is CC BY-NC, unless the funder mandates that it should be CC BY.

  10. Will publishing in BMJ Open Ophthalmology be compliant with my funder’s mandate?

    Publishing in BMJ Open Ophthalmology enables you to fulfil the Open Access requirements of various funders. Articles are published under a Creative Commons licence to facilitate reuse of the content. The standard licence is CC BY-NC, unless the funder (such as the Wellcome Trust, Research Councils UK, Austrian Science Fund, FWF, etc.) mandates that it should be their preferred CC BY licence which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. NIH employees must submit a completed and signed NIH Publishing Agreement and Manuscript Cover Sheet according to NIH’s Employee Procedures.

  11. Which funding agencies allow direct use of grants to cover the APC?

    If you received a grant to conduct your research, your first enquiry should be to whoever disburses the research funds. Much research funding is now granted on the condition that any resulting articles are published Open Access and are deposited in PubMed Central – publishing in BMJ Open Ophthalmology means that you meet both of these criteria. To help authors complete these requirements, many funders will permit payment of APCs from grants or have separate funds available.

    The Open Access Directory contains a list of universities that have funds for researchers to pay APCs. The Scholarly Publishing and Academic Resources Coalition (SPARC) has something similar – both mainly cover US institutions and are not comprehensive. The Compact for Open Access Publishing Equity is a collection of universities that have pledged support to establishing durable mechanisms for underwriting the APC model. Alternatively, contact your librarian to find out what support your institution offers.

    General information about BMJ’s Open Access Programme, including copyright policies and institutional memberships, is available via our author website.

  12. How do I subscribe?

    BMJ Open Ophthalmology is an Open Access journal allowing freely available unrestricted and immediate online access to research globally; there is no print edition. Register for email alerts to be notified when new content is available.

  13. What is the time to publication?

    BMJ Open Ophthalmology aims to provide authors with a rapid peer review service. Continuous online publication ensures papers are published as soon as they are ready. All phases of the process can be tracked via our online systems.

  14. How is the article cited?

    As an online-only journal, articles are cited by their unique article number (Digital Object Identifier or DOI) instead of by volume, issue and page number.

  15. How do I register for email alerts about BMJ Open Ophthalmology articles?

    Visit the BMJ Open Ophthalmology email alert registration page to sign up for notification when new articles have published.

  16. Who do I contact if I would like more information about BMJ Open Ophthalmology?

    For all queries please contact the editorial office at info.bmjophth@bmj.com.

Contact us

Editorial office

BMJ Open Ophthalmology Editorial Office

BMA House

Tavistock Square

London, WC1H 9JR

UK

 

Editorial Production Assistant:

Email: info.bmjophth@bmj.com

 

Production Editor: Kelly Stroud

Email: production.bmjophth@bmj.com

 

 

Publishing team

Publishing Executive: Kelly Horwood

Email khorwood@bmj.com

Tel: +44 (0) 20 7383 6318

 

Associate Publisher: Henry Spilberg

Email hspilberg@bmj.com

Tel: +44 (0) 20 7383 6057

 

 

Advertising

North America – Jim Cunningham

Email: jcunningham@cunnasso.com

Tel: +1 (201) 767-4170

 

Outside North America – Marc Clifford

Email: mclifford@bmjgroup.com

Tel: +44 (0) 20 7383 6161

 

 

Permissions

Please refer to our Permissions guidelines

 

 

Press enquiries

Guidance on BMJ Media Releases

 

Media enquiries only (9:00 to 17:00)

 

If you are a journalist needing copies of papers or press releases, please contact either:

Caroline White (BMJ Journals Press Officer)

Email: cwhite@bmjgroup.com

Tel: +44 (0)7980 800 465

 

 

Author reprints

Dennis Barber

Email: admin.reprints@bmj.com

Tel: +44 (0)20 7383 6305

 

 

Commercial reprints ROW

Nadia Gurney-Randall

Email: ngurneyrandall@bmj.com

Tel: +44 (0)20 8445 5825

Mobile: +44 (0)7866 262344

Reprint form

 

 

Online advertising sales ROW

Marc Clifford (Sales Manager)

Email: mclifford@bmj.com

Tel: +44 (0) 20 7383 6161

 

 

Print and Online Advertising Sales USA and Canada only

Jim Cunningham

Cunningham Associates, Inc.

180 Old Tappan Road

Old Tappan, NJ 07675

Email: jcunningham@cunnasso.com

Tel: +1 201 767 4170

 

 

Institutional marketing

BMJ Sales Contacts

 

 

BMJ Journals

BMJ Journals information